{"id":"W2114027444","doi":"10.2337/dc13-2855","title":"Efficacy and Safety of the Once-Weekly GLP-1 Receptor Agonist Albiglutide Versus Sitagliptin in Patients With Type 2 Diabetes and Renal Impairment: A Randomized Phase III Study","year":2014,"lang":"en","type":"article","venue":"Diabetes Care","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Sitagliptin; Type 2 diabetes; Internal medicine; Regimen; Dulaglutide; Dipeptidyl peptidase-4 inhibitor; Clinical endpoint; Adverse effect; Diabetes mellitus; Renal function; Nausea; Gastroenterology; Liraglutide; Endocrinology; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003444302,0.0002784511,0.000829684,0.0001093349,0.0001021989,0.00003123704,0.0001033242,0.00005332831,0.00002690519],"category_scores_gemma":[0.0001998213,0.0001691927,0.00007842445,0.0002562178,0.0002447883,0.00007671719,0.0001472992,0.0001233302,0.000005300007],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000819217,"about_ca_system_score_gemma":0.00002922353,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001326099,"about_ca_topic_score_gemma":0.00002548765,"domain_scores_codex":[0.9983571,0.0002197789,0.0003769128,0.000371893,0.0003211299,0.0003531827],"domain_scores_gemma":[0.9988269,0.0003636538,0.0001830327,0.0003809333,0.0001260037,0.0001194771],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.055411,0.001565324,0.9245659,0.0001730988,0.0007654494,9.047056e-7,0.002393122,0.000004515478,0.0001556777,0.00002513922,0.0001881142,0.01475176],"study_design_scores_gemma":[0.5406359,0.006302009,0.4492767,0.0003541261,0.001016737,1.528883e-8,0.0009883062,0.00006175604,0.0005425155,0.000004967878,0.0006223682,0.0001945531],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9953873,0.0004818623,3.645836e-7,0.000109974,0.0001581939,0.00318202,0.0000326295,0.0000263292,0.0006213649],"genre_scores_gemma":[0.9993954,0.00002690452,0.00009469579,0.00008735838,0.00003717167,0.0001067626,0.0001449591,0.00002811728,0.00007858061],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.485225,"threshold_uncertainty_score":0.6899478,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.00594548738920311,"score_gpt":0.2305715178757798,"score_spread":0.2246260304865767,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}